The drug has become popular as a weight-loss treatment
then gradual reintroduction of varied textures
This opposite handling of GIP signaling may lead to different biological effects
DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035 USD 72.29 BN MARKET SIZE, 2035 BIOSIMILARS MARKET SIZE, SHARE & GROWTH SNAPSHOT Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global biosimilars market is projected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, at a CAGR of 7.5% during the forecast period